Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 4Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

CNS 4

Conditions

Glioblastoma 3Brain Neoplasms 2

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Perfusion Magnetic Resonance Imaging × Clear all
NCT01604512 2025-04-08

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Memorial Sloan Kettering Cancer Center

Phase NA Completed
148 enrolled 9 charts
CNS

Brain Neoplasms

NCT04143425 2024-05-14

Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Asan Medical Center

Completed
15 enrolled
CNS

Glioblastoma

NCT02843230 2022-04-08

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Massachusetts General Hospital

Completed
30 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT01851733 2021-08-27

MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme

Washington University School of Medicine

Phase 1 Completed
37 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡